从外泌体MALAT1调节Cav-1/PI3K/AKT/mTOR轴探讨补阳还五汤促脑缺血后神经再生的机制
批准号:
82074251
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
刘柏炎
依托单位:
学科分类:
中西医结合临床基础
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
刘柏炎
中文摘要
内源性神经再生是中风康复的潜在治疗方法,但调控机制尚未明确。外泌体作为细胞间通讯的载体,将内含lncRNA等物质传递并作用于靶细胞,调控神经再生。MALAT1作为热点lncRNA,近年来发现其参与了脑发育和脑损伤保护,并可影响PI3K/Akt/mTOR通路,是中风后一个关键调节因子。Cav1既是外泌体摄入的受体,又可与RNA结合蛋白转运RNA,还是PI3K/Akt/mTOR通路的上游分子,MALAT1是否通过Cav1-PI3K/Akt/mTOR影响脑缺血后神经再生?补阳还五汤能调节Cav1- PI3K/Akt/mTOR信号轴,促进神经再生,还影响血外泌体MALAT1表达,那么,补阳还五汤是否通过影响外泌体MALAT1而调控Cav1-PI3K/Akt/mTOR轴而发挥治疗作用?项目拟从Cav1-PI3K/AKT/mTOR轴探讨MALAT1对神经再生的作用及补阳还五汤促神经再生的机理。
英文摘要
Endogenous neurogenesis is is a potential treatment for stroke rehabilitation, but the regulatory mechanism is not clear. As a carrier of intercellular communication, exosomes transfer lncRNA and others to target cells and regulate neurogenesis. More and more attention has been paid to the role of lncRNA. In recent years, Malat1, as a research hotspot, has been found to be involved in brain development and brain protection in recent years, and can affect PI3K / Akt / mTOR pathway, so Malat1 is regarded as a key regulator after stroke.Cav1 is not only a receptor that mediates exosomes intake, but transports RNA with RNA binding protein, and regulates PI3K / Akt / mTOR pathway as a upstream molecule. So, does malat1 affect neurogenesis after cerebral ischemia through cav1- PI3K / Akt / mTOR axis? Buyang Huanwu Decoction(BYHWD) can regulate PI3K / Akt / mTOR signal via Cav1, promote neurogenesis, and affect the expression of malat1 in exosome of patients. Does BYHWD play a therapeutic role by influencing the level of malat1 and the axis of cav1- PI3K / Akt / mTOR? This project aims to explore the effect of malat1 on neurogenesis and the mechanism of BYHWD in promoting neurogenesis, then reveal the new mechanism of neurogenesis regulation, and provide a new basis for the treatment of stroke with traditional Chinese medicine.
脑缺血后神经功能恢复是目前存在的难点,Cav1在此过程扮演了重要角色,外泌体作为细胞内外交流的载体,调控机体的生理病理过程,但Cav1与外泌体的关系尚不明确。项目在体证实了Cav1能够调节脑缺血小鼠缺血侧皮质区外泌体MALAT1的表达,影响脑缺血小鼠缺血侧皮质区PI3K/AKT/mTOR通路及YAP1/HIF-1α通路的活性,并调控脑缺血后的神经再生。补阳还五汤能够通过Cav1提高脑缺血小鼠缺血侧皮质区外泌体MALAT1的表达,调控脑缺血小鼠缺血侧皮质区YAP1/HIF-1α通路的活性,进而促进神经再生,还能抑制脑缺血小鼠GPX4、铁水平及脂质过氧化,调控脑缺血小鼠的线粒体质量控制。细胞实验证实Cav1沉默会抑制细胞存活率和迁移能力,并抑制外泌体的摄入;Cav1沉默会降低OGD/R损伤细胞上清液外泌体MALAT1的表达,减少OGD/R损伤细胞YAP1/HIF-1α通路的活性。补阳还五汤含药血清能够通过Cav1提高细胞外泌体MALAT1的表达,调控YAP1/HIF-1α通路的活性。此外,运用单细胞测序发现补阳还五汤改变了脑缺血小鼠缺血侧皮质的细胞构成、基因表达谱、细胞间通讯的作用及机制;能够促进脑缺血后星形胶质细胞向神经元转分化,其作用机制可能与通过Cav1调控Shh信号通路,上调各神经分化因子的表达有关。项目共发表论文19篇(SCI6篇)。培养博士5人,硕士3人。
wnt/β-catenin通路与caveolin1串话在脑缺血后神经再生的作用及补阳还五汤的影响
-
批准号:81273989
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2012
-
负责人:刘柏炎
-
依托单位:
从caveolin1/notch1信号探讨补阳还五汤促脑缺血后神经再生的机理
-
批准号:30873355
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2008
-
负责人:刘柏炎
-
依托单位:
从脑缺血后内源性干细胞的神经再生探讨补阳还五汤疗效机理
-
批准号:30300470
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2003
-
负责人:刘柏炎
-
依托单位:
国内基金
海外基金